首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1458024

全球生物標記市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球生物標記市場需求預計將從 2023 年的 578 億美元增至 2032 年的近 1,480.9 億美元，2024-2032 年研究期間複合CAGR為 11.02%。

生物標記是可以在生物樣本中檢測到的可測量的指示劑或物質，並提供有關各種生理或病理過程的資訊。生物標記廣泛應用於醫學研究和診斷，可以指示疾病的存在、進展或對治療的反應。例子包括血液或組織中的蛋白質、基因或特定分子。生物標記在個人化醫療中發揮著至關重要的作用，有助於識別高風險個體、早期疾病檢測和監測治療效果。

市場動態

生物標記在疾病診斷、預後和監測治療反應中發揮著至關重要的作用，有助於個人化醫療方法。癌症和心血管疾病等慢性疾病負擔的激增推動了市場的成長。基因組學、蛋白質組學和代謝組學技術的進步有助於識別新型生物標記物，擴大其應用範圍。早期疾病檢測、及時介入、改善患者治療結果以及對精準醫療和標靶治療的日益重視進一步推動市場成長。對生物標記驗證和批准流程的監管支持增強了其與臨床實踐的融合。對各種疾病的研發投資不斷增加，促進了市場的持續成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球生物標記市場的每個細分市場進行了包容性評估。生物標記物產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

生物標記市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品和服務

耗材
服務
裝置

按類型

安全生物標記
易感性/風險生物標記
診斷生物標記
預後生物標記
監測生物標記
預測性生物標記
藥效/反應生物標記

按申請

診斷
藥物發現與開發
個人化醫療
疾病風險評估
其他

按疾病適應症

癌症
神經系統疾病
心血管疾病
傳染性疾病
免疫系統疾病
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲生物標記物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

按地區分類的全球生物標記市場佔有率（代表性圖）
全球生物標記市場佔有率

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。生物標記市場的主要參與者包括 Abbott Laboratories、Agilent Technology、Becton、Dickinson and Company、Bio-Rad Laboratories、BioMerieux SA (Astute Medical)、Merck KGaA、Qiagen NV、Quanterix、Quest Diagnostics、Thermo Fisher Scientific Inc。包括 Fisher Scientific Inc。包括對競爭格局的整體看法，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品和服務分類的市場吸引力分析
- 按類型分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 依疾病適應症進行的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球生物標記市場分析：按產品和服務分類

按產品和服務分類的概述
歷史和預測數據
按產品和服務分析
耗材
服務
裝置

第 6 章：全球生物標記市場分析：按類型

按類型概述
歷史和預測數據
按類型分析
安全生物標記
易感性/風險生物標記
診斷生物標記
預後生物標記
監測生物標記
預測性生物標記
藥效/反應生物標記

第 7 章：全球生物標記市場分析：按應用分類

概述：按應用
歷史和預測數據
分析：按應用
診斷
藥物發現與開發
個人化醫療
疾病風險評估
其他

第 8 章：全球生物標記市場分析：按疾病適應症

按疾病適應症概述
歷史和預測數據
按疾病指徵分析
癌症
神經系統疾病
心血管疾病
傳染性疾病
免疫系統疾病
其他

第 9 章：全球生物標記市場分析：按地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：生物標記物公司的競爭格局

生物標記市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

公司股份分析
市場集中度
Abbott Laboratories

公司簡介
公司收入
產品
最近的發展

Agilent Technology

公司簡介
公司收入
產品
最近的發展

Becton

公司簡介
公司收入
產品
最近的發展

Dickinson and Company

公司簡介
公司收入
產品
最近的發展

Bio-Rad Laboratories

公司簡介
公司收入
產品
最近的發展

BioMerieux SA (Astute Medical)

公司簡介
公司收入
產品
最近的發展

Merck KGaA

公司簡介
公司收入
產品
最近的發展

Qiagen NV

公司簡介
公司收入
產品
最近的發展

Quanterix

公司簡介
公司收入
產品
最近的發展

Quest Diagnostics

公司簡介
公司收入
產品
最近的發展

Thermo Fisher Scientific Inc.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113891

The global demand for Biomarkers Market is presumed to reach the market size of nearly USD 148.09 BN by 2032 from USD 57.80 BN in 2023 with a CAGR of 11.02% under the study period 2024 - 2032.

Biomarkers are measurable indicators or substances that can be detected in biological samples and provide information about various physiological or pathological processes. Widely used in medical research and diagnostics, biomarkers can indicate the presence, progression, or response to treatment of diseases. Examples include proteins, genes, or specific molecules in blood or tissue. Biomarkers play a vital role in personalized medicine, aiding in identifying at-risk individuals, early disease detection, and monitoring treatment efficacy.

MARKET DYNAMICS

Biomarkers play a vital role in disease diagnosis, prognosis, and monitoring treatment responses, contributing to personalized medicine approaches. The surging burden of chronic diseases, such as cancer and cardiovascular disorders, fuels the market growth. Advances in genomics, proteomics, and metabolomics technologies contribute to identifying novel biomarkers, expanding the scope of their applications. Early disease detection, enabling timely interventions, improved patient outcomes, and growing emphasis on precision medicine and targeted therapies further propel market growth. Regulatory support for biomarker validation and approval processes enhances their integration into clinical practice. The rising investments in research and development for various diseases contribute to the market's continuous growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biomarkers. The growth and trends of biomarkers industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Consumables
Services
Equipment

By Type

Safety Biomarkers
Susceptibility/Risk Biomarkers
Diagnostic Biomarkers
Prognostic Biomarkers
Monitoring Biomarkers
Predictive Biomarkers
Pharmacodynamic/Response Biomarkers

By Application

Diagnostics
Drug Discovery & Development
Personalized Medicine
Disease Risk Assessment
Others

By Disease Indication

Cancer
Neurological Disorders
Cardiovascular Disorders
Infectious Diseases
Immune Disorders
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL BIOMARKERS MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global Biomarkers Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biomarkers market include Abbott Laboratories, Agilent Technology, Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux SA (Astute Medical), Merck KGaA, Qiagen NV, Quanterix, Quest Diagnostics, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BIOMARKERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Disease Indication
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BIOMARKERS MARKET ANALYSIS BY PRODUCT & SERVICE

5.1 Overview by Product & Service
5.2 Historical and Forecast Data
5.3 Analysis by Product & Service
5.4 Consumables Historic and Forecast Sales by Regions
5.5 Services Historic and Forecast Sales by Regions
5.6 Equipment Historic and Forecast Sales by Regions

6 . GLOBAL BIOMARKERS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Safety Biomarkers Historic and Forecast Sales by Regions
6.5 Susceptibility/Risk Biomarkers Historic and Forecast Sales by Regions
6.6 Diagnostic Biomarkers Historic and Forecast Sales by Regions
6.7 Prognostic Biomarkers Historic and Forecast Sales by Regions
6.8 Monitoring Biomarkers Historic and Forecast Sales by Regions
6.9 Predictive Biomarkers Historic and Forecast Sales by Regions
6.10. Pharmacodynamic/Response Biomarkers Historic and Forecast Sales by Regions

7 . GLOBAL BIOMARKERS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Diagnostics Historic and Forecast Sales by Regions
7.5 Drug Discovery & Development Historic and Forecast Sales by Regions
7.6 Personalized Medicine Historic and Forecast Sales by Regions
7.7 Disease Risk Assessment Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL BIOMARKERS MARKET ANALYSIS BY DISEASE INDICATION

8.1 Overview by Disease Indication
8.2 Historical and Forecast Data
8.3 Analysis by Disease Indication
8.4 Cancer Historic and Forecast Sales by Regions
8.5 Neurological Disorders Historic and Forecast Sales by Regions
8.6 Cardiovascular Disorders Historic and Forecast Sales by Regions
8.7 Infectious Diseases Historic and Forecast Sales by Regions
8.8 Immune Disorders Historic and Forecast Sales by Regions
8.9 Others Historic and Forecast Sales by Regions

9 . GLOBAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE BIOMARKERS COMPANIES

10.1. Biomarkers Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF BIOMARKERS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Abbott Laboratories
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Agilent Technology
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Becton
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Dickinson and Company
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Bio-Rad Laboratories
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. BioMerieux SA (Astute Medical)
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Merck KGaA
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Qiagen NV
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Quanterix
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Quest Diagnostics
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Thermo Fisher Scientific Inc.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments